NCT00305552View on ClinicalTrials.gov

SARCOTHAL. Thalidomide in Skin Sarcoidosis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Sarcoidosis
Interventions
DRUG

THALIDOMIDE

THALIDOMIDE

Trial Locations (1)

75010

HOPITAL Saint Louis, Service de Dermatologie, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00305552 - SARCOTHAL. Thalidomide in Skin Sarcoidosis | Biotech Hunter | Biotech Hunter